Luzi Andreas von Bidder was until recently Chairman of the Swiss listed company Acino Holding AG and is currently on the Board of several other private healthcare companies including Ferring and Solvias. Prior to Acino, he served as Chairman and Chief Executive Officer of Novartis Ophthalmics AG and as a member of the Novartis Pharma Executive Committee and with Ciba-Geigy in various positions. Luzi Andreas von Bidder graduated in Economics from HSG University of St. Gallen.